Stemtech Corporation has entered into a licensing agreement with a third-party distributor in Taiwan and will close the Stemtech Taiwan Holding, Taiwan Branch operation.
Original Acquisition On May 7, 2018, the Company purchased the assets of Stemtech International, Inc. (the “Former Parent Company”), out of a Chapter 7 Bankruptcy for $ 400,000 and the assumption of …
ng the application of ASC 815-40 Contracts in Entity's Own Equity to its outstanding convertible notes and warrants. Pursuant to the sequencing approach, the Company evaluates its contracts based upo…
le App, in September 2022, improving communication, sharing of information, training videos and other content for recruiting, on-boarding, customer retention and measuring key performance indicators …
hysiology, also known as stem cell enhancers. Known as the Stem Cell Nutrition Company®, the Company is a pioneer in stem cell science, and believes it can demonstrate that adult stem cells function …
e consideration paid was 2.4 million shares of the Company with a fair value of $ 271,920 . At the time of purchase, LFR’s liabilities exceeded its assets by $15,205, and the difference between the n…
e consideration paid was 2.4 million shares of the Company with a fair value of $ 271,920 . At the time of purchase, LFR’s liabilities exceeded its assets by $15,205, and the difference between the n…
Stemtech Corporation Debt Obligations
Instrument
Description
Confidence
Evidence
STEK-DEBT-12776
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2024-12-31.
STEK-DEBT
Debt stack $4.9M
90%
Market cache reports total debt of $4.9M.
Stemtech Corporation Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Stemtech Corporation.
Stemtech Corporation Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Stemtech Corporation.
